Michael Griffith becomes executive vice president of inVentiv Health
April 8, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv
inVentiv Health has appointed Michael Griffith as its new executive vice president. In this capacity, Griffith will head inVentiv’s commercial …
Roche joins forces with PatientsLikeMe
April 8, 2014Medical Communications, Research and Development, Sales and Marketing Novartis, PatientsLikeMe, Roche, UCB, real-word data
PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …
Pfizer breast cancer drug combo aces trial
April 7, 2014Femera, Pfizer, breast cancer, oncology, palbociclib
Under fire Ranbaxy sold to Sun Pharma for $4 billion
April 7, 2014Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, deal, hamburg, manufacturing
Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …
Celgene ‘stops Mylan entering market’
April 6, 2014Sales and Marketing Celgene, Mylan, Revlimid, myeloma
Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …
Alzheimer’s disease: pharma’s greatest challenge
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy
Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
NICE U-turn on Roche cancer drug
April 4, 2014Medical Communications, Sales and Marketing NICE, Roche, Tarceva, U-turn
Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …
Novartis sues Biocon
April 4, 2014Sales and Marketing Biocon, Galvus, Gilead, Herceptin, Novartis, sofosbuvir
India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …
Fishawack buys JK Associates
April 4, 2014Medical Communications 1010 Digital., Arbor Communications, Endpoint Medical Communications, JK Medical Communications, fishawack, jk associates
Medical communications firm Fishawack has acquired JK Associates in a bid to significantly expand the company’s presence in the US. …
AbbVie drops EMA legal case after compromise
April 4, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials
AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …
‘BrainSpan’ 3D technology could help drug development
April 4, 2014Medical Communications, Sales and Marketing NIH, brainscan, digital, nimh
A new three-dimensional atlas of the developing human brain has been made available in the hope that it can help …
EMG appoints new chair and officers
April 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMG, Sanofi, oldfield
Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG). Oldfield …
‘E-tattoo’ could help deliver drugs into patients
April 4, 2014Medical Communications, Sales and Marketing device, digital, etattoo, nature, wearable tech
Researchers have created a new wearable device that is as thin as a temporary tattoo and can store and transmit …
More manufacturing misery for GSK
April 4, 2014Manufacturing and Production, Sales and Marketing GSK, Ireland, Paxil, cork, manufacturing
GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …
Glythera makes two senior appointments
April 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing burns, evetts, glythera
Newcastle-based biotech firm Glythera has appointed Dr Nigel Burns as non-executive director and Ian Evetts as commercial director. Burns (pictured) …
FDA slams GSK for manufacturing oversights
April 3, 2014Manufacturing and Production FDA, GMP, GSK, Ireland, cork, mage, manufacturing
The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …
Steve McCairns joins PCI as UK director
April 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing PCI, mccairns
Packaging firm PCI has welcomed Steve McCairns as its director of operations for its UK business.

 McCairns is a Lean …
EU votes for trial transparency
April 3, 2014Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott
Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
